Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Low biologic aggressiveness in breast cancer in women using hormone replacement therapy.

Holli K, Isola J, Cuzick J.

J Clin Oncol. 1998 Sep;16(9):3115-20.

PMID:
9738583
2.

Type and duration of exogenous hormone use affects breast cancer histology.

Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES.

Ann Surg Oncol. 2007 Feb;14(2):695-703. Epub 2006 Nov 14.

PMID:
17103262
3.

Association of regimens of hormone replacement therapy to prognostic factors among women diagnosed with breast cancer aged 50-64 years.

Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Marchbanks PA, Coates RJ, Norman SA, Weiss LK, Ursin G, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1175-81.

4.

Pathologic and biological prognostic factors of breast cancers in short- and long-term hormone replacement therapy users.

Sacchini V, Zurrida S, Andreoni G, Luini A, Galimberti V, Veronesi P, Intra M, Viale G, Veronesi U.

Ann Surg Oncol. 2002 Apr;9(3):266-71.

PMID:
11923133
5.

Clinical and biological characteristics of breast cancers in post-menopausal women receiving hormone replacement therapy for menopause.

Salmon RJ, Ansquer Y, Asselain B, Languille O, Lesec G, Remvikos Y.

Oncol Rep. 1999 May-Jun;6(3):699-703.

PMID:
10203618
6.

The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers.

Pappo I, Meirshon I, Karni T, Siegelmann-Danielli N, Stahl-Kent V, Sandbank J, Wasserman I, Halevy A.

Ann Surg Oncol. 2004 Jan;11(1):52-8.

PMID:
14699034
7.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
8.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
10.

Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.

Schuetz F, Diel IJ, Pueschel M, von Holst T, Solomayer EF, Lange S, Sinn P, Bastert G, Sohn C.

Am J Obstet Gynecol. 2007 Apr;196(4):342.e1-9.

PMID:
17403414
11.

Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.

Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.

Cancer. 2004 Oct 1;101(7):1490-500.

12.

Estrogen replacement therapy and breast cancer: analysis of age of onset and tumor characteristics.

Bilimoria MM, Winchester DJ, Sener SF, Motykie G, Sehgal UL, Winchester DP.

Ann Surg Oncol. 1999 Mar;6(2):200-7.

PMID:
10082047
13.

A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.

Olsson H, Borg A, Ewers SB, Fernö M, Möller T, Ranstam J.

Med Oncol Tumor Pharmacother. 1986;3(2):77-81.

PMID:
3747639
14.

Breast cancer diagnosed during hormone replacement therapy.

Gajdos C, Tartter PI, Babinszki A.

Obstet Gynecol. 2000 Apr;95(4):513-8.

PMID:
10725482
15.

Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.

Prasad R, Boland GP, Cramer A, Anderson E, Knox WF, Bundred NJ.

Cancer. 2003 Dec 15;98(12):2539-46.

16.

Estrogen replacement therapy and breast cancer survival in a large screening study.

Schairer C, Gail M, Byrne C, Rosenberg PS, Sturgeon SR, Brinton LA, Hoover RN.

J Natl Cancer Inst. 1999 Feb 3;91(3):264-70.

17.

Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.

O'Meara ES, Rossing MA, Daling JR, Elmore JG, Barlow WE, Weiss NS.

J Natl Cancer Inst. 2001 May 16;93(10):754-62.

18.

The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival.

Sener SF, Winchester DJ, Winchester DP, Du H, Barrera E, Bilimoria M, Krantz S, Rabbitt S.

Am J Surg. 2009 Mar;197(3):403-7. doi: 10.1016/j.amjsurg.2008.11.014.

PMID:
19245923
19.

The effect of hormone replacement therapy on prognostic indices in women with breast cancer.

Jones C, Ingram D, Mattes E, Hahnel R.

Med J Aust. 1994 Jul 18;161(2):106-10.

PMID:
8028534
20.

Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study.

Tjønneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewertz M, Mellemkjaer L.

Cancer. 2004 Jun 1;100(11):2328-37.

Items per page

Supplemental Content

Write to the Help Desk